Novo Nordisk India and Healthify Partners to Launch AI Enabled Patient Support Programme

Novo Nordisk India has partnered with Healthify to launch an AI enabled patient support programme aimed at individuals receiving treatment for obesity.  

The platform offers guidance on lifestyle, nutrition and adherence, combining digital support with clinical treatment pathways. 

Key Development 

The programme uses Healthify’s AI coaching technology to help patients maintain nutrition goals, activity patterns and routine lifestyle changes throughout their treatment period.  

The digital assistance is structured to work alongside therapy prescribed by healthcare professionals, aiming to strengthen consistency and reduce drop-offs that commonly occur in long-term obesity management. 

Key Insights & Impact  

According to the organisations, patients often struggle with behaviour change that accompanies obesity treatment. The AI system provides real-time prompts, structured recommendations and practical actions that simplify the process.  

Leadership involved in the initiative noted that the integration of medical therapy with guided lifestyle support can meaningfully improve outcomes and enhance the patient journey. This partnership signals growing interest in combining clinical treatment with continuous lifestyle coaching to strengthen long-term health outcomes. 

Read More: Reliance Industries Share Price in Focus as Subsidiary Acquires 49% Stake in Oval Invincibles! 

Conclusion 

The collaboration between Novo Nordisk India and Healthify marks a step forward in the use of technology for chronic condition management in the country. By bringing structured digital coaching into obesity care, the programme aims to address gaps that often hinder progress, such as inconsistent adherence and limited follow-up support.  

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.  

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.